Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kumquat Biosciences
Kumquat Biosciences is a small molecule oncology company backed by Roche and Eli Lilly.
Biotech
Bayer picks Kumquat for $1.3B KRAS collaboration
Bayer has tapped Kumquat for a juicy opportunity, committing up to $1.3 billion to bag a KRAS G12D inhibitor that is on the cusp of the clinic.
Nick Paul Taylor
Aug 12, 2025 6:29am
Takeda inks sweet $1.2B-plus immuno-oncology deal with Kumquat
Apr 16, 2024 11:34am
